Arkolith/Insider Trading/KMTS/Form 4

Webster Brian Daniel

See Remarks, DirectorKESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) · full profile →Form 4 · filed Feb 19, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$384K
Net Open-Market Flow
-$384K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 17, 2026Sell(S)3K$26.29$86K380K
Feb 17, 2026Sell(S)93$27.18$3K380K
Feb 17, 2026Sell(S)12K$25.39$295K383K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-059532) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML